Title : Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver Transplantation.

Pub. Date : 2018 Dec

PMID : 30556034






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) is currently approved for treatment of HCV in patients with prior treatment with DAAs. Sofosbuvir small integral membrane protein 1 (Vel blood group) Homo sapiens